谁面临肾切除术后的死亡风险?英国泌尿外科医师协会(BAUS)全国肾切除术审计3年内21 380例肾切除术后30天死亡率分析
该回顾性分析基于英国泌尿外科医师协会(BAUS)全国肾切除术审计中21 380例肾切除术,30天内死亡110例,总体30天死亡率为0.5%。根治性、部分、单纯肾切除和肾输尿管切除术的30天死亡率分别为0.6%、0.1%、0.4%和0.9%。年龄、分期、估计失血量、手术时间和体能状态与30天死亡率升高相关;估计失血量1-2 L和微创手术中转与死亡风险升高相关。
要点
- 英国肾切除术后总体30天死亡率为0.5%(110/21 380)。
- 根治性、部分、单纯肾切除和肾输尿管切除术的30天死亡率分别为0.6%、0.1%、0.4%和0.9%。
- 估计失血量1-2 L(OR 1.38;95% CI 1.03-2.24)和微创手术中转(OR 2.53;95% CI 1.14-4.51)是新识别的风险因素。
核心结论
- 本研究提供了所有类型肾切除术真实风险的当代见解,英国肾切除术后30天死亡率0.5%似乎可接受地低。
- 已确立的风险因素得到确认,并识别出以下新风险因素:中等估计失血量(1-2 L)和微创手术中转。
研究设计与样本
- 对英国泌尿外科医师协会(BAUS)全国肾切除术审计中3年内21 380例肾切除术中30天内发生的110例死亡进行回顾性分析。
- 根据围手术期特征计算30天死亡率的比值比(OR)和95%置信区间(CI)。
主要发现
- 总体30天死亡率为110/21 380(0.5%)。
- 根治性、部分、单纯肾切除和肾输尿管切除术的30天死亡率分别为0.6%(63/11 057)、0.1%(4/3 931)、0.4%(11/2 819)和0.9%(28/3 091)。
- 30天死亡率随年龄、分期、估计失血量(EBL)、手术时间和体能状态增加而升高。
- 估计失血量1-2 L与2-5 L相比,30天死亡风险更高(OR 1.38;95% CI 1.03-2.24)。
- 微创手术中转与非中转相比风险更高(OR 2.53;95% CI 1.14-4.51);根治性手术与减瘤手术相比更安全(OR 0.31;95% CI 0.18-0.54)。
关键数值与推荐
- 总体30天死亡率:110/21 380(0.5%)。
- 根治性肾切除术30天死亡率:0.6%(63/11 057)。
- 部分肾切除术30天死亡率:0.1%(4/3 931)。
- 单纯肾切除术30天死亡率:0.4%(11/2 819)。
- 肾输尿管切除术30天死亡率:0.9%(28/3 091)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To ascertain contemporary overall and differential thirty-day mortality (TDM) rates after all types of nephrectomy in the UK, and to identify potential new risk factors for death. PATIENTS AND METHODS: We conducted a retrospective analysis of the 110 deaths that occurred within 30 days of surgery out of the total of 21 380 nephrectomies performed, and calculated the odds ratio (OR) and 95% confidence interval (CI) for TDM based on peri-operative characteristics. RESULTS: The overall TDM rate was 110/21380 (0.5%). The TDM rates after radical, partial, simple nephrectomy and nephro-ureterectomy were 0.6% (63/11057), 0.1% (4/3931), 0.4% (11/2819) and 0.9% (28/3091), respectively. TDM increased with age, stage, estimated blood loss (EBL), operating time and performance status. EBL of 1-2 L was associated with a greater risk of TDM than EBL of 2-5 L (OR 1.38; 95% CI 1.03-2.24). Conversion from minimally invasive surgery was associated with higher risk than non-conversion (OR 2.53; 95% CI 1.14-4.51. Curative surgery was safer than cytoreductive surgery (OR 0.31; 95% CI 0.18-0.54). There was an association between surgical volume and TDM. CONCLUSIONS: This study provides contemporary insights into the true risks of all types of nephrectomy. The TDM rate after nephrectomy in the UK appears acceptably low at 0.5%. Established risk factors were confirmed and the following novel risk factors were identified: modest EBL (1-2 L) and conversion from minimally invasive surgery.
引用
- Fernando A, Fowler S, Van Hemelrijck M, et al. Who is at risk of death from nephrectomy? An analysis of thirty-day mortality after 21 380 nephrectomies in 3 years of the British Association of Urological Surgeons (BAUS) National Nephrectomy Audit. BJU Int. 2017. PMID: 28440053. doi:10.1111/bju.13842
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。